For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Kiel 24148

0 studies enrolling now · 6 studies all time

What they study most

Lymphoma, Follicular, Melanoma, Plaque Psoriasis, Psoriasis, Sepsis

Studies at this site

• A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3) — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Phase 3 Study in Participants With Moderate to Severe Psoriasis — Completed
• A Study of Enzastaurin in Participants With Follicular Lymphoma — Completed
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed